Negara: Selandia Baru
Bahasa: Inggris
Sumber: Medsafe (Medicines Safety Authority)
Temozolomide 250mg
Merck Sharp & Dohme (New Zealand) Limited
Temozolomide 250 mg
250 mg
Capsule
Active: Temozolomide 250mg Excipient: Colloidal silicon dioxide Gelatin Lactose Sodium laurilsulfate Sodium starch glycolate Stearic acid Tartaric acid TekPrint black SW-9008 TekPrint black SW-9010 Titanium dioxide
Bottle, glass, Amber with CR closure, 5 capsules
Prescription
Prescription
Ampac Fine Chemicals LLC
Package - Contents - Shelf Life: Bottle, glass, Amber with CR closure - 5 capsules - 36 months from date of manufacture stored at or below 25°C - Sachet, PET or Polyester/Al/LLDPE unit dose x 5 - 5 capsules - 36 months from date of manufacture stored at or below 25°C
1998-03-11
TEMODAL ® 1 TEMODAL ® _Temozolomide _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about TEMODAL. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking TEMODAL against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT TEMODAL IS USED FOR TEMODAL is used to treat patients with brain tumours. TEMODAL is also used to treat adult patients with advanced metastatic malignant melanoma. Your doctor, however, may prescribe TEMODAL for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY TEMODAL HAS BEEN PRESCRIBED FOR YOU. TEMODAL belongs to a group of medicines called cytotoxic or chemotherapy medicines. TEMODAL works by killing cancer cells and stopping cancer cells from growing and multiplying. This medicine is only available with a doctor's prescription. _USE IN CHILDREN _ Temodal capsules are used to treat children 3 years and older, with specific forms of brain tumour (glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy). BEFORE YOU TAKE TEMODAL _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE TEMODAL IF: 1. YOU ARE ALLERGIC TO TEMODAL (TEMOZOLOMIDE), DACARBAZINE (DTIC) OR ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET. Symptoms of an allergic reaction may include: − hives, itching or skin rash − swelling of the face, lips or tongue. This may lead to difficulty swallowing. − shortness of breath, wheezing, difficulty breathing or a Baca dokumen lengkapnya
A20130806 Version 13 Page 1 of 11 NEW ZEALAND DATA SHEET TEMODAL CAPSULES Temozolomide NAME OF MEDICINE TEMODAL Temozolomide 5 mg, 20 mg, 100 mg, 140 mg*, 180 mg* and 250 mg capsules * not currently distributed in New Zealand PRESENTATION TEMODAL Capsules TEMODAL capsules have a white body. The colour of the cap for the 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg strength capsules is respectively green, yellow, pink, blue, orange and white. The cap is imprinted with "TEMODAL". The body is imprinted with two stripes, "the strength" and the Schering-Plough logo. The colour of the imprinting is black. Each capsule contains temozolomide, lactose, sodium starch glycollate, stearic acid, tartaric acid and colloidal anhydrous silica in a gelatin capsule shell. TEMODAL capsule shells contain titanium dioxide, sodium lauryl sulfate and gelatin, and are imprinted with TekPrint SW-9008 Black Ink (ARTG No: 2328) or TekPrint SW-9010 Black Ink (ARTG No: 1656). TEMODAL 5 mg capsule shells also contain Indigo Carmine CI73015 and Iron Oxide Yellow CI77492. TEMODAL 20 mg capsule shells also contain Iron Oxide Yellow CI77492. TEMODAL 100 mg capsule shells also contain Iron Oxide Red CI77491. TEMODAL 140 mg capsule shells also contain Indigo Carmine CI73015. TEMODAL 180 mg capsule shells also contain Iron Oxide Red CI77491 and Iron Oxide Yellow CI77492. Temozolomide is imidazol[5,1-_d_]-1,2,3,5-tetrazine-8-carboxamide,3,4-dihydro-3-methyl-4-oxo. It has CAS Registry Number: 85622-93-1; Molecular Formula: C 6 H 6 N 6 O 2 ; MW: 194.15 USES _ACTIONS _ TEMODAL is an imidazotetrazine alkylating agent with antitumour activity. It undergoes rapid chemical conversion in the systemic circulation at physiological pH to the active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity Baca dokumen lengkapnya